U.S. market Closed. Opens in 11 hours 22 minutes

IPHA | Innate Pharma S.A. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
Revenue51.90M49.64M12.11M56.83M68.97M79.89M32.63M56.16M17.91M907.00K12.47M10.38M11.74M4.32M7.72M12.92M14.29M6.20M1.30M
Cost of Revenue56.02M51.66M47.00M3.04M45.16MN/AN/AN/AN/A12.09M7.58M6.86M1.64M3.43M3.35M2.56M2.77M2.20M944.00K
Gross Profit-4.12M-2.02M-34.89M53.79M23.82M79.89M32.63M56.16M17.91M-11.18M4.89M3.51M10.10M893.00K4.37M10.37M11.52M3.99M356.00K
Operating Expenses69.22M66.06M59.94M75.38M50.87M74.75M72.61M48.59M28.68M8.76M7.66M6.88M17.67M14.58M19.90M21.37M20.61M11.18M6.77M
Selling, General & Admin17.09M22.44M25.52M30.39M49.58M19.25M16.18M9.33M5.88M12.82M10.67M9.73M9.79M13.33M18.58MN/AN/A1.84M1.08M
Research & Development52.13M51.66M47.00M58.61M1.60M69.56M67.00M48.63M29.91MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/A-8.04M-12.59M-13.62M-309.00K-14.06M-10.57M-9.37M-7.11M-4.06M-3.00M-2.85M7.88M1.26M1.33M21.37M20.61M9.34M5.69M
Operating Income-22.41M-11.65M-47.83M-13.69M-27.05M5.15M-39.98M7.57M-10.77M-19.94M-2.77M-3.37M-7.57M-13.69M-15.54M-11.01M-9.09M-7.19M-6.42M
Other Expenses / Income5.11M-46.32M2.35M-50.29M6.29M-2.14M-8.03M5.37M4.07M294.00K-119.00K170.00K590.00K32.00K909.00K1.15M173.00K1.15M286.00K
Before Tax Income-17.30M-57.97M-45.48M-63.98M-20.76M2.72M-48.02M12.94M-6.71M-19.65M-2.89M-3.20M-6.98M-13.66M-14.63M-9.85M-8.92M-6.04M-6.13M
Income Tax Expenses-9.73M41.13M13.66M6.76M206.00K-333.00K368.00K301.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-7.57M-99.10M-59.14M-70.75M-20.96M3.05M-48.38M12.64M-6.71M-19.65M-2.89M-3.20M-6.98M-13.66M-14.63M-9.85M-8.92M-6.04M-6.13M
Interest Expenses640.00K5.32M4.00M6.76M204.00K102.00K113.00K124.00K139.00K165.00K194.00K225.00K520.00KN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding80.45M79.64M79.54M78.93M66.91M58.78M54.35M53.87M53.40M50.15M38.70M37.80M37.69M37.44M26.30M25.66M25.08M17.77M14.90M
Diluted Shares Outstanding80.45M79.64M79.54M78.93M66.91M58.78M54.35M53.87M53.40M50.15M38.70M37.80M37.69M37.44M26.30M25.66M25.08M17.77M14.90M
EBITDA-17.32M33.75M-36.88M43.10M-8.88M12.36M-43.51M16.33M-3.91M-17.14M-1.82M-2.13M-5.56M-12.56M-13.60M-9.31M-8.38M-5.74M-5.83M
EBITDA Margin-33.36%68.00%-304.53%75.85%-12.88%15.48%-133.34%29.07%-21.85%-1,889.53%-14.58%-20.57%-47.35%-290.69%-176.30%-72.06%-58.66%-92.72%-448.31%
EBIT-16.66M-52.65M-41.48M-57.22M-20.55M2.82M-47.90M13.06M-6.57M-19.48M-2.70M-2.97M-6.46M-13.66M-14.63M-9.85M-8.92M-6.04M-6.13M
EBIT Margin-32.10%-106.07%-342.48%-100.68%-29.80%3.53%-146.81%23.26%-36.67%-2,147.96%-21.64%-28.66%-55.03%-316.16%-189.55%-76.23%-62.41%-97.53%-471.46%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙